In conversation with...

Eva Feldman on advances in understanding ALS

April 13, 2022 The Lancet Neurology
In conversation with...
Eva Feldman on advances in understanding ALS
Show Notes

Eva Feldman (University of Michigan, Ann Arbor, USA) discusses the latest advances in the genetics, risk factors, pathophysiology, therapeutic development, and the diagnosis and prognosis of amyotrophic lateral sclerosis; the Series is published in the May issue of The Lancet Neurology.